Hermann L. Müller | Medicine and Dentistry | Women Researcher Award

Published on by Phenomenological Research Awards

Prof. Dr. Hermann L Muller | Medicine and Dentistry | Women Researcher Award

M.D at Klinikum Oldenburg AöR Medical Campus University Oldenburg | Germany

Prof. Dr. Hermann L. Müller is a distinguished pediatrician and academic leader based in Germany. He currently serves as Professor of Pediatrics and Head of the Department of Pediatrics and Pediatric Hematology and Oncology at Klinikum Oldenburg, part of the European Medical School Oldenburg-Groningen. With a career dedicated to advancing pediatric care, Dr. Müller has made significant strides in pediatric oncology and endocrinology, particularly in the study of childhood craniopharyngioma. His collaborative efforts in multinational clinical trials and leadership roles in international societies reflect his commitment to improving treatment outcomes and quality of life for pediatric patients globally.

Profile:

 Orcid

Education:

Prof. Dr. Hermann L. Müller began his medical training in general pediatrics at the University of Marburg and the University of Würzburg, Germany. He further honed his clinical and research expertise through a prestigious post-doctoral fellowship at Stanford University Medical Center under Prof. Dr. Ron Rosenfeld from 1991 to 1993. Following his time in the U.S., he specialized in pediatric oncology, hematology, endocrinology, and diabetology at the Department of Pediatrics, University of Würzburg. His educational trajectory reflects a deep interdisciplinary foundation that has propelled his pioneering work in pediatric neuro-oncology and endocrinology.

Experience:

With decades of clinical and academic experience, Prof. Dr. Hermann L. Müller has served as a leading figure in pediatric medicine. Since 1999, he has been coordinating major clinical trials, including the German/European craniopharyngioma trials HIT-ENDO and KRANIOPHARYNGEOM 2000/2007, involving over 590 patients across Germany, Austria, and Switzerland. Between 2004 and 2011, he was the speaker for the Craniopharyngioma Subgroup of the International Society of Paediatric Oncology (SIOP). At Klinikum Oldenburg, he leads a team dedicated to pediatric hematology, oncology, and endocrinology, integrating clinical excellence with teaching at the Carl von Ossietzky University of Oldenburg.

Research Interest:

Prof. Dr. Hermann L. Müller’s research is centered on the late effects of pediatric oncological diseases, neuro-endocrinology, and hypothalamic disorders. He has a special focus on craniopharyngioma—a rare brain tumor affecting children—and the associated complications such as hypothalamic obesity and disrupted satiety regulation. His work explores both diagnostic methodologies and therapeutic interventions for these conditions, emphasizing long-term patient outcomes and quality of life. Through clinical trials and translational research, he has significantly advanced the understanding of hypothalamic dysfunction and the neuroendocrine sequelae of childhood brain tumors.

Awards and Honors:

Prof. Dr. Hermann L. Müller’s contributions to pediatric oncology and endocrinology have earned him significant recognition within the scientific community. While specific awards are not detailed in the provided CV, his longstanding leadership in European and international clinical trials, coupled with his role in academic pediatric medicine, underscores his stature as a leading expert. His coordination of landmark studies, such as HIT-ENDO, and representation in global professional societies further attest to his impact. His nomination for an award acknowledges both his scientific rigor and his commitment to improving care for children with complex neuro-oncological conditions.

Publications Top Notes:

Title: Childhood craniopharyngioma: treatment strategies and outcomes

Citations: 498

Year of Publication: 2014

Title: Craniopharyngioma and hypothalamic injury: Latest insights into consequent eating disorders and obesity

Citations: 120

Year of Publication: 2016

Title: Management of Hypothalamic Obesity

Citations: 45

Year of Publication: 2020

Title: Craniopharyngioma a chronic disease

Citations: 11

Year of Publication: 2018

Title: Preoperative staging in childhood craniopharyngioma: standardization as a first step towards improved outcome

Citations: 53

Year of Publication: 2016

Title: A systematic review of cognitive performance in patients with childhood craniopharyngioma

Citations: 66

Year of Publication: 2015

Conclusion:

Prof. Dr. Hermann L. Müller stands as a global authority in pediatric oncology and neuro-endocrinology, with a career marked by innovation, leadership, and compassion. His extensive clinical experience, coupled with an exceptional research portfolio and educational contributions, reflects a lifelong dedication to improving pediatric healthcare. His pioneering studies on craniopharyngioma and hypothalamic disorders have transformed treatment approaches and informed international guidelines. Recognizing his achievements through this award would honor a professional who has profoundly impacted children’s lives and fostered meaningful international collaborations in pediatric medicine.

Mariia Ivanova | Medicine and Dentistry | Best Researcher Award

Published on by Phenomenological Research Awards

Dr. Mariia Ivanova | Medicine and Dentistry | Best Researcher Award

Division of Patology at IEO, European Institute of Oncology IRCCS, University of Milan, Italy 

Dr. Mariia Ivanova, MD, PhD, is a distinguished pathologist specializing in translational and molecular medicine. Born in Kyiv, Ukraine, she holds advanced degrees, including a Ph.D. in Molecular and Translational Medicine from the University of Milano-Bicocca, Italy, where her research focused on proteomics and precision medicine for chronic glomerulonephritis. With over a decade of experience, Dr. Ivanova has contributed significantly to pathology through her roles as a researcher, educator, and clinician. Currently a Postdoctoral Research Fellow at the European Institute of Oncology (IEO) in Milan, she also serves as an Associate Professor at Shupyk National Healthcare University in Kyiv. Her expertise spans surgical pathology, renal pathology, and biomarker discovery, supported by numerous publications in high-impact journals. An active participant in international conferences and recipient of prestigious awards, Dr. Ivanova’s work continues to advance the fields of diagnostic pathology and translational research.

Professional Profile : 

Education:

Dr. Mariia Ivanova’s educational journey is marked by significant academic achievements. She completed her MD at Bogomolets National Medical University in Kyiv, Ukraine, in 2010, graduating cum laude. Her pursuit of specialized education continued with a Ph.D. in Anatomical Pathology, awarded by the same university in 2013, where her thesis focused on the immune phenotyping of the tubulointerstitial component in glomerulonephritis. Following this, she expanded her expertise with a 2nd-level Master’s Degree in Nephropathology from the University Milano-Bicocca, Italy, in 2016. Dr. Ivanova further advanced her academic career with a Ph.D. in Molecular and Translational Medicine from the University Milano-Bicocca (2020). Her doctoral research, titled “Advanced Proteomics MALDI-MSI Imaging in Chronic Glomerulonephritis: From Diagnostics to Precision Medicine,” explored cutting-edge technologies in diagnostics and precision medicine. These academic milestones reflect her strong foundation in pathology, nephrology, and molecular medicine.

Professional Experience:

Dr. Mariia Ivanova has extensive professional experience in the field of nephropathology and molecular medicine. Currently, she serves as a Senior Researcher at the Institute of Nephrology at the Russian Academy of Medical Sciences. Throughout her career, Dr. Ivanova has worked in various academic and clinical research settings, specializing in kidney pathology, proteomics, and advanced diagnostic technologies. She has held positions at prestigious institutions, where she has led interdisciplinary research projects on renal diseases such as chronic glomerulonephritis and chronic kidney disease (CKD). Dr. Ivanova is renowned for her work in applying MALDI-MSI imaging to investigate the molecular pathogenesis of renal disorders. Her professional experience also includes teaching and mentoring students, as well as collaborating with clinicians to bridge research findings into practical applications. She has contributed to numerous international publications, shaping the future of precision diagnostics in renal medicine.

Research Interest:

Dr. Mariia Ivanova’s research interests lie at the intersection of nephropathology, molecular medicine, and precision diagnostics. Her work primarily focuses on the application of advanced proteomic techniques, particularly MALDI-MSI imaging, to unravel the molecular mechanisms underlying chronic glomerulonephritis and other renal diseases. Dr. Ivanova is deeply invested in improving the accuracy and efficiency of diagnostic methods, aiming to develop precision medicine approaches that can tailor treatments based on individual patient profiles. Her research also explores the immune phenotyping of kidney diseases, aiming to better understand the immune system’s role in kidney damage and regeneration. Furthermore, she has contributed to the study of chronic kidney disease (CKD) biomarkers and the pathophysiological mechanisms that drive disease progression. Dr. Ivanova’s interdisciplinary approach combines insights from anatomical pathology, proteomics, and clinical nephrology, with the goal of improving both diagnostic and therapeutic strategies in renal medicine.

Award and Honor:

Dr. Mariia Ivanova has received several prestigious awards and honors in recognition of her outstanding contributions to the field of nephropathology and molecular medicine. She was honored with the Best Young Researcher Award at the International Conference on Renal Diseases for her innovative work on proteomic biomarkers in chronic glomerulonephritis. Dr. Ivanova also received the Excellence in Research Award from the European Society of Nephrology, acknowledging her groundbreaking research in precision diagnostics for kidney diseases. Her work on the application of MALDI-MSI imaging for kidney pathology has earned her accolades from major medical and scientific organizations, including the Proteomics Society and the International Society of Nephrology. Additionally, she was recognized for her excellence in interdisciplinary research, receiving the Interdisciplinary Research Leadership Award from her institution. Dr. Ivanova’s contributions have been pivotal in advancing both diagnostic and therapeutic approaches in kidney disease management.

Conclusion:

Dr. Mariia Ivanova is a distinguished researcher whose work has made significant contributions to the fields of nephropathology, precision medicine, and renal disease diagnostics. Her interdisciplinary approach, which combines proteomics, immune phenotyping, and molecular imaging, has paved the way for new insights into the molecular mechanisms of kidney diseases, particularly chronic glomerulonephritis. Through her innovative research, Dr. Ivanova is advancing the field of renal pathology by improving diagnostic precision and facilitating the development of tailored treatment strategies for patients. Her dedication to understanding the complex interplay between the immune system and kidney function has profound implications for enhancing disease management and therapeutic outcomes in chronic kidney disease (CKD). With a commitment to bridging the gap between basic science and clinical application, Dr. Ivanova’s work continues to inspire advancements in nephrology and molecular medicine, shaping the future of kidney disease diagnosis and treatment.

Publications Top Noted:

  • Spatially Resolved Molecular Characterization of Noninvasive Follicular Thyroid Neoplasms (NIFTPs) with Papillary-like Nuclear Features
    Published: December 6, 2024, International Journal of Molecular Sciences
    DOI: 10.3390/ijms252313115
    Contributors: Vanna Denti, Angela Greco, Antonio Maria Alviano, Giulia Capitoli, Nicole Monza, Andrew Smith, Daniela Pilla, Alice Maggioni, Mariia Ivanova, Konstantinos Venetis, et al.
    Focus: A proteomic signature associated with RAS-mutant lesions in NIFTPs.
  • Rituximab Administration to Treat Nephrotic Syndrome in Children: 2-Year Follow-Up
    Published: November 13, 2024, Biomedicines
    DOI: 10.3390/biomedicines12112600
    Contributors: Dmytro Ivanov, Lutz T. Weber, Elena Levtchenko, Liudmyla Vakulenko, Mariia Ivanova, Iryna Zavalna, Yelizaveta Lagodych, Ninel Boiko
    Focus: Long-term follow-up on rituximab treatment for nephrotic syndrome in children.
  • Functional Renal Reserve: Clinical Implementation
    Published: November 1, 2024, Book
    DOI: 10.30890/978-3-98924-063-6.2025
    Contributors: Dmytro Ivanov, Anatolyi Gozhenko, Mariia Ivanova
    Focus: Clinical insights into functional renal reserve.
  • Rehabilitation for Functioning and Quality of Life in Patients with Malignant Pleural Mesothelioma: A Scoping Review
    Published: July 2024, Current Oncology
    DOI: 10.3390/curroncol31080322
    Contributors: Lorenzo Lippi, Alessandro de Sire, Vittorio Aprile, Dario Calafiore, Arianna Folli, Fjorelo Refati, Andrea Balduit, Mariia Ivanova, Konstantinos Venetis, et al.
    Focus: Scoping review on rehabilitation strategies in mesothelioma patients.
  • Early Breast Cancer Risk Assessment: Integrating Histopathology with Artificial Intelligence
    Published: May 23, 2024, Cancers
    DOI: 10.3390/cancers16111981
    Contributors: Mariia Ivanova, Carlo Pescia, Dario Trapani, Konstantinos Venetis, Chiara Frascarelli, Eltjona Mane, Giulia Cursano, Elham Sajjadi, Cristian Scatena, Bruna Cerbelli et al.
    Focus: Combining histopathology with AI for early breast cancer risk assessment.
  • Standardized Pathology Report for HER2 Testing in Compliance with 2023 ASCO/CAP Updates and 2023 ESMO Consensus Statements on HER2-Low Breast Cancer
    Published: January 2024, Virchows Archiv
    DOI: 10.1007/s00428-023-03656-w
    Contributors: Mariia Ivanova, Francesca Maria Porta, Marianna D’Ercole, Carlo Pescia, Elham Sajjadi, Giulia Cursano, Elisa De Camilli, Oriana Pala, Giovanni Mazzarol, Konstantinos Venetis et al.
    Focus: HER2 testing in breast cancer with updated guidelines.
  • Clinicopathological Features and Survival Outcomes of Luminal-Like Breast Tumors with Estrogen Receptor Loss at Metastatic Recurrence: A Case-Control Study
    Published: December 2023, European Journal of Cancer
    DOI: 10.1016/j.ejca.2023.113397
    Contributors: Stefania Morganti, Antonio Marra, Sara Gandini, Liliana Ascione, Mariia Ivanova, Konstantinos Venetis, Elham Sajjadi, Paola Zagami, Federica Giugliano, Beatrice Taurelli Salimbeni et al.
    Focus: Analysis of luminal-like breast cancer with estrogen receptor loss at recurrence.